Profile: Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery & development of drugs to treat human cancers and other serious disorders. We generate anticancer drugs that act on the cell cycle, including cyclin dependent kinase (CDK) and aurora kinase (AK) inhibitors. Sapacitabine (CYC682), a cell cycle modulating nucleoside analog, is used for the treatment of acute myeloid leukemia and lung cancer. We provide seliciclib which is a CDK inhibitor used for the treatment of lung cancer and nasopharyngeal cancer. We have drugs for cancer, inflammatory kidney disease, HIV/AIDS and for type 2 diabetes.